image4 image5
707 237 2656
image7 image8 spacer23


image10 spacer21


Initial observations from clinical research on colds and sinus infections is engaging, as show below. Other promising clinical observations for Respigard are being conducted in the U.S., as well as India. One acute upper respiratory tract infections study is ongoing in New Delhi, India (1 in 2 children have URTIs). The Atlanta Allergy and Asthma Institute is conducting an emphysema/COPD study and one for allergies and asthma. Dr. Scott Carroll, an independent MD, has conducted a clinical observation study showing that 79% of the time there is full resolution of bronchial and nasal symptoms of the common cold—within 12-48 hours. Further, Dr. Carroll is doing an observational study at The Atlanta Allergy and Asthma Institute on how well Respigard words with emphysema/COPD patients. There have been dozens of reports from clients that the solution has helped them.

There are independent double-blind studies (50% placebo and 50% with the product with researchers unaware of whom has what) that are observing the solution’s efficacy on colds, flu and other respiratory infections, allergies, asthma, emphysema/COPD.

Research from Dr. Scott Carroll

Click here for a PDF of Dr. Carroll’s report>







  The products listed on this site are not to be considered substitutes for professional medical care. If you are sick, you should consult your physician. If you are currently taking any medication, consult your physician before you decide to use any herbal or other natural related products. This site and the products listed on it are not intended to diagnose, treat, cure or prevent any specific disease, nor are they appropriate as a substitute for professional care or medical consultation. These statements have not been evaluated by the Food and Drug Administration.  
  © 2013 Best Natural Cold Flu Season Site Design: JRA write|design spacer15
spacer14 spacer13 spacer12 spacer11 spacer10 spacer9 spacer8 spacer7 spacer6 spacer5 spacer4 spacer3 spacer2 spacer1